Rosiglitazone XR
Sponsors
GlaxoSmithKline
Conditions
Alzheimer's DiseaseArthritis, Rheumatoid
Phase 1
Phase 2
Phase 3
Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
TerminatedNCT00490568
Start: 2007-08-08End: 2009-06-01Updated: 2017-11-13
Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
TerminatedNCT00550420
Start: 2007-10-01End: 2009-02-12Updated: 2017-11-08